Alfasigma opens new doors in the US with Intercept acquisition

Retrieved on: 2023-11-08 19:58:29

Tags for this article:

Pharmaceuticals policy

Hepatology

Orphan drugs

Bile acids

Cholanes

Intercept Pharmaceuticals

Obeticholic acid

Primary biliary cholangitis

Food and Drug Administration

Pharmaceutical industry in China

Click the tags to see associated articles and topics

Alfasigma opens new doors in the US with Intercept acquisition. View article details on hiswai:

Excerpt

... Medical Device (SaMD) · Accelerating Biopharmaceutical Innovation · Precision ... device identifiers or other similar technologies on your device and ...

Article found on: www.pharmaceutical-technology.com

View Original Article